1,080 material Form 8-K filings that 839 companies we cover made with the SEC in May 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Ulta Beauty reported first-quarter fiscal 2025 results for the period ended May 3, 2025, with net sales up 4.5% to $2.8 billion and diluted earnings per share of $6.70, versus $6.47 a year earlier. Net income fell to $305.1 million from $313.1 million, and operating margin declined to 14.1% from 14.7%. The company raised its fiscal 2025 diluted EPS outlook to $22.65 to $23.20 from $22.50 to $22.90.
Net sales rose 4.5% to $2.8 billion; comparable sales increased 2.9%, driven by a 2.3% rise in average ticket and a 0.6% rise in transactions.
Diluted EPS was $6.70 versus $6.47, while net income declined to $305.1 million from $313.1 million and the effective tax rate rose to 24.6% from 23.2%.
Fiscal 2025 outlook: diluted EPS raised to $22.65 to $23.20 from $22.50 to $22.90; net sales raised to $11.5 billion to $11.7 billion; comparable sales raised to 0% to 1.5%.
Share repurchases of $358.7 million in the quarter; $2.3 billion remained under the $3.0 billion program as of May 3, 2025.
NetApp reported fourth-quarter fiscal 2025 net revenues of $1.73 billion, up 4% from a year earlier, and GAAP net income of $340 million, or $1.65 per share, compared with $291 million and $1.37 a year earlier. The company guided fiscal 2026 net revenues to $6.625 billion to $6.875 billion and authorized up to an additional $1.1 billion in share repurchases, while Executive Vice President and Chief Product Officer Harvinder Bhela plans to leave that role by June 20, 2025.
Q4 fiscal 2025 net revenues $1.73 billion, up 4% year over year; GAAP EPS $1.65 vs. $1.37
Fiscal 2026 net revenue guidance $6.625 billion to $6.875 billion; GAAP EPS guidance $5.80 to $6.10
Board authorized up to an additional $1.1 billion in stock repurchases on May 22, 2025, with no expiration date
Chief Product Officer Harvinder Bhela to transition out of his role by June 20, 2025
Bath & Body Works reported first quarter 2025 net sales of $1,424 million, up 2.9%, and earnings of $0.49 per diluted share, up from $0.38, with EPS above the high end of its guidance range. The company maintained its full-year 2025 guidance and gave second quarter EPS guidance of $0.33 to $0.38, and it said the CEO transition could reduce 2025 EPS by about $0.05, which its guidance excludes.
Q1 net sales $1,424 million, up 2.9% from $1,384 million; diluted EPS $0.49 vs. $0.38, above the high end of guidance.
Full-year 2025 guidance maintained: net sales growth of 1% to 3% and diluted EPS of $3.25 to $3.60, including current tariff rates.
Q2 2025 guidance: net sales flat to up 2%; diluted EPS of $0.33 to $0.38, vs. $0.37 adjusted EPS in Q2 2024.
Daniel Heaf appointed CEO effective May 16, 2025; the company estimates the transition could reduce 2025 EPS by about $0.05.
Pure Storage reported first quarter fiscal 2026 revenue of $778.5 million, up 12% year over year, and a GAAP net loss of $14.0 million, narrower than the $35.0 million loss a year earlier. The company also said Chief Financial Officer Kevan Krysler will leave, and that he will stay until a successor is named and that the departure does not relate to financial statement or accounting issues.
Revenue $778.5 million, up 12% year over year; subscription services revenue $406.3 million, up 17%
GAAP operating loss of $31.2 million, versus $41.8 million a year earlier; non-GAAP operating income $82.7 million
Guidance: second quarter revenue of $845 million; fiscal 2026 revenue of $3.515 billion, up 11%
CFO Kevan Krysler to leave; he remains until a successor is named
Cavco Industries reported fiscal fourth-quarter 2025 net revenue of $508 million, up 21% from a year earlier, and diluted earnings per share of $4.47 versus $4.03. The board also approved a new $150 million stock repurchase program on May 20, 2025, which the company expects to fund from existing cash.
Q4 net revenue was $508 million, up 21% from $420 million; GAAP diluted EPS was $4.47 versus $4.03.
Adjusted diluted EPS was $5.40, excluding a $10.0 million non-cash charge tied to legacy brand intangibles.
The board approved a new $150 million stock repurchase program on May 20, 2025; timing and amount are at the company's discretion and it may be suspended at any time.
Deckers reported fiscal 2025 net sales up 16.3% to $4.986 billion and diluted EPS up 30% to $6.33, and gave a first-quarter fiscal 2026 outlook but no full-year guidance because of trade policy uncertainty. The board also raised the share repurchase authorization by $2.25 billion to about $2.5 billion and named Cynthia Davis Chair, succeeding Michael Devine III, who is retiring.
Fiscal 2025 net sales rose 16.3% to $4.986 billion; diluted EPS rose to $6.33 from $4.86.
Fourth-quarter net sales rose 6.5% to $1.022 billion; diluted EPS was $1.00 versus $0.82.
First-quarter fiscal 2026 outlook: net sales of $890 million to $910 million and diluted EPS of $0.62 to $0.67; no full-year fiscal 2026 guidance was given.
Buyback authorization increased by $2.25 billion to about $2.5 billion; Cynthia Davis became Chair effective May 22, 2025.
Intuit reported revenue of $7.8 billion for the fiscal third quarter ended April 30, 2025, up 15 percent, and raised its full-year fiscal 2025 guidance across total company metrics. The company also declared a quarterly dividend of $1.04 per share.
Q3 revenue of $7.8 billion, up 15 percent; GAAP diluted EPS of $10.02, up 19 percent; non-GAAP diluted EPS of $11.65, up 18 percent
Fiscal 2025 revenue guidance of $18.723 billion to $18.760 billion, growth of about 15 percent, up from prior guidance of 12 to 13 percent
Fiscal 2025 non-GAAP diluted EPS guidance of $20.07 to $20.12, up from prior growth guidance of 13 to 14 percent
Dividend of $1.04 per share payable July 18, 2025, to holders of record as of July 10, 2025
Ralph Lauren reported fourth-quarter and full-year fiscal 2025 results, with revenue and reported earnings per share both higher than a year earlier. The company also raised its quarterly dividend 10% and approved a new $1.5 billion share repurchase program, and it gave a preliminary fiscal 2026 outlook calling for low-single-digit constant-currency revenue growth.
Q4 revenue rose 8% to $1.7 billion on a reported basis and 10% in constant currency
Q4 reported EPS was $2.03 versus $1.38 a year earlier; adjusted EPS was $2.27 versus $1.71
Full-year fiscal 2025 revenue rose 7% to $7.1 billion; reported EPS was $11.61 versus $9.71
Quarterly dividend increased 10% to $0.9125 per share; new $1.5 billion repurchase program authorized
Keysight reported second-quarter fiscal 2025 revenue of $1.31 billion, up from $1.22 billion a year earlier, and non-GAAP earnings of $1.70 per share, up from $1.41. The company said revenue and EPS were above the high end of its guidance and raised its full-year growth expectations to the midpoint of its long-term 5-7% target. Separately, director Robert A. Rango retired from the board effective May 15, 2025, for personal reasons.
Q2 revenue was $1.31 billion versus $1.22 billion in Q2 2024; GAAP diluted EPS was $1.49 versus $0.72.
Non-GAAP diluted EPS was $1.70 versus $1.41 a year earlier; free cash flow was $457 million versus $74 million.
Third-quarter fiscal 2025 revenue is expected at $1.305 billion to $1.325 billion, with non-GAAP EPS of $1.63 to $1.69.
Director Robert A. Rango retired from the board effective May 15, 2025, for personal reasons, not due to a disagreement with the company.
Bath & Body Works appointed Daniel Heaf, formerly a leader at Nike, as chief executive effective May 16, 2025, and Gina Boswell left the CEO role and the Board that day. The company also pre-announced preliminary first-quarter results, with net sales up 3% and earnings per diluted share above the prior year, and kept its full-year 2025 outlook unchanged.
Daniel Heaf became CEO effective May 16, 2025, and will join the Board after the 2025 Annual Meeting of Shareholders; Gina Boswell stepped down as CEO and director the same day.
Preliminary first-quarter net sales were $1,424 million, up 3% from the prior year, at the high end of guidance.
Diluted EPS was $0.49, compared with $0.38 a year earlier, above the high end of guidance; results remain subject to closing procedures.
Full-year 2025 guidance was maintained at net sales growth of 1% to 3% and EPS of $3.25 to $3.60, reflecting the initial 10% tariff on goods imported from China.
CAVA Group reported fiscal first-quarter 2025 results for the 16 weeks ended April 20, 2025, with restaurant revenue up 28.2% and net income more than doubling to $25.7 million. The company also raised its fiscal 2025 guidance for adjusted EBITDA to $152.0 million to $159.0 million and for net new restaurant openings to 64 to 68.
CAVA restaurant revenue was $328.5 million, up 28.2% from $256.3 million, with same restaurant sales growth of 10.8%.
Net income was $25.7 million, or $0.22 per diluted share, compared with $14.0 million, or $0.12 per diluted share, a year earlier. Net income included a $10.7 million income tax benefit related to equity-based compensation.
Restaurant-level profit margin was 25.1%, compared with 25.2% a year earlier, as input costs and wage investments offset higher sales.
Fiscal 2025 adjusted EBITDA guidance was raised to $152.0 million to $159.0 million from $150.0 million to $157.0 million on May 15, 2025.
Boot Barn reported fourth-quarter and fiscal 2025 results for the periods ended March 29, 2025, with net sales up 16.8% to $453.7 million and net income of $37.5 million, or $1.22 per diluted share, versus $0.96 a year earlier. The board also authorized up to $200 million in share repurchases, and the company gave fiscal 2026 guidance with diluted EPS of $5.50 to $6.40 against $5.88 in fiscal 2025.
Q4 net sales rose 16.8% to $453.7 million; consolidated same store sales rose 6.0%.
Fiscal 2025 net income was $180.9 million, or $5.88 per diluted share, up from $4.80.
Board authorized repurchases of up to $200 million of common stock with no expiration date.
Fiscal 2026 guidance: total sales of $2.070 billion to $2.150 billion and diluted EPS of $5.50 to $6.40.
Exelixis reported first-quarter 2025 total revenues of $555.4 million, up from $425.2 million a year earlier, and GAAP diluted earnings per share of $0.55, up from $0.12. The company raised its 2025 total revenue guidance by $100 million, to $2.25 billion to $2.35 billion, and net product revenue guidance to $2.05 billion to $2.15 billion, citing growth in CABOMETYX demand.
Q1 2025 total revenues were $555.4 million, versus $425.2 million in Q1 2024; net product revenues were $513.3 million.
GAAP diluted EPS was $0.55 and non-GAAP diluted EPS was $0.62, versus GAAP diluted EPS of $0.12 in Q1 2024.
2025 total revenue guidance is now $2.25 billion to $2.35 billion, up from $2.15 billion to $2.25 billion.
Stock repurchases totaled $494.5 million through March 31, 2025, at an average price of $34.87 per share.
StandardAero reported first-quarter 2025 revenue of $1.4 billion, up 16.2% from a year earlier, and net income of $62.9 million, compared with $3.2 million in the prior-year quarter. The company raised its full-year 2025 revenue and Adjusted EBITDA guidance, which now includes an estimated $15 million net impact from announced tariffs.
Revenue of $1,435.6 million, up 16.2% from $1,235.7 million; diluted EPS of $0.19 versus $0.01 a year earlier
Net income of $62.9 million, helped by $33.8 million lower interest expense than the prior-year quarter
2025 revenue guidance raised to $5.8 billion to $6.0 billion (from $5.8 billion to $6.0 billion prior range); Adjusted EBITDA guidance raised to $775 million to $795 million from $770 million to $790 million
Arrowhead Pharmaceuticals reported fiscal second-quarter 2025 results for the period ended March 31, 2025, with revenue of $542.7 million versus none a year earlier and net income attributable to the company of $370.4 million, compared with a loss of $125.3 million in the prior-year quarter. The company also said it expects to be funded into 2028 following its Sarepta Therapeutics agreement, and that its CFO, Ken Myszkowski, will retire effective May 13, 2025, succeeded by Daniel Apel.
Net income attributable to Arrowhead was $370.4 million, or $2.75 per diluted share, versus a loss of $1.02 per share a year earlier.
Research and development expenses rose to $133.1 million from $101.1 million.
CFO Ken Myszkowski retires effective May 13, 2025; Daniel Apel succeeds him.
Construction Partners reported fiscal second-quarter revenue of $571.7 million, up 54% from a year earlier, and net income of $4.2 million, or $0.08 per diluted share, compared with a net loss of $1.1 million in the same quarter last year. The company raised its fiscal 2025 outlook, citing the expected contribution of the recently acquired PRI and its second-quarter results. The filing also reports a May 8 executive reorganization that changed some officer titles, with Gregory A. Hoffman taking on the principal accounting officer role in addition to his CFO duties.
Q2 revenue was $571.7 million, up from $371.4 million; acquisitions completed since March 31, 2024 contributed $173.1 million of the $200.3 million increase.
Net income was $4.2 million, or $0.08 per diluted share, versus a net loss of $1.1 million a year earlier.
Fiscal 2025 revenue outlook was raised to $2.77 billion to $2.83 billion; net income outlook was raised to $106.0 million to $117.0 million.
Gregory A. Hoffman became principal accounting officer in addition to CFO; Fred J. (Jule) Smith, III remains President and CEO, and the filing states no compensation changes.
HCI Group reported first quarter 2025 pre-tax income of $100.3 million and net income after noncontrolling interests of $69.7 million, up from $47.6 million a year earlier. The board is pursuing a potential tax-free spin-off of its Exzeo Group unit to existing HCI shareholders, targeted for completion by the end of 2025, subject to customary conditions.
Diluted EPS was $5.35 in Q1 2025 versus $3.81 in Q1 2024
Gross premiums earned rose 17.0% to $300.4 million, driven mainly by policies assumed from Citizens Property Insurance Corporation
Losses and loss adjustment expenses fell to $59.3 million from $79.9 million; gross loss ratio was 19.7% versus 31.1%
Potential Exzeo spin-off targeted for completion by the end of 2025; IRS tax-free treatment is not assured
Progyny reported first quarter 2025 revenue of $324.0 million, up 16.5% from a year earlier, and raised its full year 2025 outlook, projecting revenue of $1.185 billion to $1.235 billion. GAAP net income fell to $15.1 million from $16.9 million, while adjusted earnings per diluted share rose to $0.48 from $0.39, so shareholders get a mixed profit picture alongside stronger sales and guidance.
Q1 2025 revenue was $324.0 million, up 16.5%; excluding a large client that did not renew, revenue rose 19%
Net income was $15.1 million, or $0.17 per diluted share, versus $16.9 million, or $0.17, a year earlier, due mainly to a higher tax provision
Adjusted EBITDA rose 15% to $57.8 million; operating cash flow was $49.8 million versus $25.7 million
Full year 2025 guidance: revenue $1.185 billion to $1.235 billion, adjusted EBITDA $190.0 million to $203.0 million; Q2 2025 revenue projected at $310.0 million to $325.0 million
Adtalem Global Education Inc. (NYSE: ATGE) reported third-quarter fiscal 2025 revenue of $466.1 million, up 12.9%, and diluted EPS of $1.59 versus $0.93 a year earlier, and raised its fiscal 2025 guidance. The Board also authorized a new $150 million share repurchase program through May 2028. Note that the filing is from Adtalem, not Covista Inc. (CVSA) as the request header states.
Revenue of $466.1 million, up 12.9% year over year; net income of $60.8 million versus $36.8 million
Adjusted EPS of $1.92 versus $1.50 a year earlier; diluted EPS of $1.59 versus $0.93
Fiscal 2025 guidance raised to revenue of $1,760 million to $1,775 million and adjusted EPS of $6.40 to $6.60
New $150 million share repurchase program through May 2028, following completion of a $300 million program on May 5, 2025
TKO reported first quarter 2025 revenue of $1.27 billion, up 4%, and net income of $165.5 million, compared with a net loss of $234.5 million a year earlier, which included a $335.0 million legal settlement charge in the prior-year period. The company raised its full-year 2025 revenue and Adjusted EBITDA targets for UFC and WWE, excluding the acquired IMG, On Location and PBR businesses, and separately set combined targets that include those businesses.
Q1 2025 revenue was $1,268.8 million, up from $1,222.4 million; Adjusted EBITDA rose 23% to $417.4 million
Excluding the acquired businesses, 2025 revenue guidance rose to $3.005 billion to $3.075 billion from $2.930 billion to $3.000 billion
Including the acquired businesses, 2025 guidance is revenue of $4.490 billion to $4.560 billion and Adjusted EBITDA of $1.490 billion to $1.530 billion
Cash and cash equivalents were $470.9 million and gross debt was $2.776 billion as of March 31, 2025
Toast reported first-quarter 2025 net income of $56 million, compared with a net loss of $83 million a year earlier, and Adjusted EBITDA of $133 million, up from $57 million. The company raised its full-year 2025 Adjusted EBITDA outlook to $540 million to $560 million from $510 million to $530 million, which signals higher expected profitability for shareholders.
Q1 2025 net income was $56 million versus a net loss of $83 million in Q1 2024.
Total revenue was $1.34 billion in Q1 2025 versus $1.08 billion in Q1 2024.
Full-year 2025 Adjusted EBITDA outlook raised to $540 million to $560 million from $510 million to $530 million.
Toast signed Dine Brands' Applebee's, which it describes as its largest deal to date.
Lyft reported first-quarter 2025 revenue of $1.5 billion, up 14% from a year earlier, and net income of $2.6 million, compared with a net loss of $31.5 million in the first quarter of 2024. Its board also raised the share repurchase authorization by $250 million to a total of $750 million, and the company guided to second-quarter Gross Bookings of $4.41 billion to $4.57 billion.
Revenue of $1.5 billion, up 14% year over year; Gross Bookings of $4.2 billion, up 13%
Net income of $2.6 million versus a net loss of $31.5 million in Q1 2024
Adjusted EBITDA of $106.5 million versus $59.4 million; free cash flow of $280.7 million versus $127.1 million
Repurchase authorization increased by $250 million to $750 million; the company intends to use $500 million within 12 months
Federal Realty Investment Trust reported first quarter 2025 results on May 8, 2025. FFO was $146.5 million, or $1.70 per diluted share, up from $136.7 million, or $1.64, a year earlier, and net income available for common shareholders was $61.8 million, or $0.72 per diluted share, versus $0.66. The company raised its 2025 FFO per diluted share guidance to $7.11 to $7.23 from $7.10 to $7.22 and kept its 2025 earnings per diluted share guidance at $3.00 to $3.12.
Q1 2025 FFO of $146.5 million, or $1.70 per diluted share, compared with $1.64 in Q1 2024
Net income available for common shareholders of $61.8 million, or $0.72 per diluted share, compared with $0.66
2025 FFO per diluted share guidance raised to $7.11 to $7.23; 2025 EPS guidance unchanged at $3.00 to $3.12
Comparable portfolio occupancy was 93.6% at March 31, 2025, up 180 basis points year over year
Yelp reported first-quarter 2025 net revenue of $359 million, up 8% from a year earlier, with net income of $24 million, or $0.36 per diluted share, versus $0.20 a year earlier. The company also updated its 2025 outlook to net revenue of $1.465 billion to $1.485 billion and adjusted EBITDA of $345 million to $365 million, which matters to shareholders because it sets the company's full-year targets.
Q1 2025 net revenue was $359 million, up 8% year over year and $4 million above the high end of the company's first-quarter outlook range.
Net income was $24 million, up 72% from $14 million, with diluted earnings of $0.36 per share versus $0.20 a year earlier.
Adjusted EBITDA was $85 million, up 32%, and $15 million above the high end of the company's outlook range.
2025 outlook: net revenue of $1.465 billion to $1.485 billion and adjusted EBITDA of $345 million to $365 million.
TransMedics reported first quarter 2025 revenue of $143.5 million, up 48% from $96.9 million a year earlier, and net income of $25.7 million, or $0.70 per diluted share, versus $12.2 million in the prior-year quarter. The company raised its full-year 2025 revenue guidance to $565 million to $585 million from the previous $530 million to $552 million range, which both headline measures and the outlook point to stronger results for shareholders.
Q1 2025 total revenue was $143.5 million, a 48% increase from $96.9 million in Q1 2024.
Net income was $25.7 million, or $0.70 per fully diluted share, compared with $12.2 million, or $0.35 per diluted share, a year earlier.
Full-year 2025 revenue guidance was raised to $565 million to $585 million from $530 million to $552 million, as reported February 27, 2025; gross margin was 61% versus 62% a year earlier.
APA reported first-quarter 2025 net income attributable to common stock of $347 million, or $0.96 per diluted share, compared with $132 million, or $0.44, a year earlier, and total revenues of $2.6 billion versus $1.95 billion. The company cut its 2025 development capital guidance by $150 million and agreed to sell its New Mexico Permian assets to Permian Resources for $608 million, with proceeds expected mainly to reduce debt.
Q1 2025 adjusted earnings were $385 million, or $1.06 per diluted share, versus $237 million, or $0.78, in Q1 2024
2025 development capital guidance reduced by $150 million; full-year U.S. oil production guidance of 125,000 to 127,000 barrels per day maintained
Expected 2025 cost savings raised to $130 million from $60 million previously; annualized run-rate target of $225 million by year-end
New Mexico asset sale to Permian Resources Corporation (NYSE: PR) for $608 million, expected to close late in the second quarter
ACI Worldwide reported first-quarter 2025 revenue of $395 million, up 25% from a year earlier, and net income of $59 million compared with a net loss of $8 million in the prior-year quarter. The company raised its full-year 2025 revenue guidance, while keeping its adjusted EBITDA outlook unchanged, and CFO Scott Behrens announced his retirement, with no effective date set yet and a successor still being sought.
Q1 2025 revenue was $395 million, up 25%, and net income was $59 million, including a $22 million after-tax gain on the sale of a minority interest in Mindgate
Full-year 2025 revenue guidance raised to $1.690 billion to $1.720 billion from $1.685 billion to $1.715 billion; adjusted EBITDA guidance unchanged at $480 million to $495 million
Q2 2025 guidance: revenue of $375 million to $385 million and adjusted EBITDA of $55 million to $65 million
Scott Behrens will retire as EVP, CFO and Chief Accounting Officer, effective on a date to be determined; the company is identifying a successor
Maximus reported fiscal second-quarter 2025 revenue of $1.36 billion, up 1.0%, and diluted EPS of $1.69, up from $1.31 a year earlier. The company raised its fiscal 2025 revenue guidance to $5.25 billion to $5.4 billion and its adjusted diluted EPS guidance to $6.30 to $6.60, its second consecutive guidance raise. Shareholders also receive a $0.30 quarterly dividend payable May 31, 2025.
Q2 revenue rose 1.0% to $1.36 billion, with organic growth of 3.0% led by U.S. Federal Services.
Diluted EPS was $1.69 vs. $1.31 a year earlier; adjusted diluted EPS was $2.01 vs. $1.57.
FY25 guidance: revenue $5.25 billion to $5.4 billion; adjusted diluted EPS $6.30 to $6.60; free cash flow $355 million to $385 million (unchanged).
U.S. Services revenue fell 9.0% to $442.4 million, and days sales outstanding rose to 73 days from 62 days.
Life Time Group Holdings reported first-quarter 2025 results on May 8, 2025, with total revenue of $706.0 million, up 18.3% from a year earlier, and net income of $76.1 million, up 205.6%. The company raised its full-year 2025 outlook, including revenue guidance of $2,940 million to $2,980 million and net income guidance of $286 million to $293 million, which matters to shareholders because it signals higher expected earnings for the year.
Q1 2025 diluted EPS was $0.34, up from $0.12 in Q1 2024; net income included a $14.6 million tax benefit from stock option exercises
Adjusted EBITDA rose 31.2% to $191.6 million; net debt leverage ratio fell to 2.0 times from 3.6 times a year earlier
2025 guidance: revenue of $2,940 million to $2,980 million and Adjusted EBITDA of $792 million to $808 million; comparable center revenue growth raised to 8.5% to 9.5% from 7% to 8%
Life Time signed a letter of intent on May 6, 2025 for a sale-leaseback of three properties for approximately $150 million in gross proceeds
US Foods reported fiscal first-quarter 2025 net sales of $9.4 billion, up 4.5%, and net income of $115 million, up 40.2% from a year earlier. The company reaffirmed its fiscal 2025 guidance and authorized a new $1 billion share repurchase program, which it expects to use for more meaningful buybacks starting in the second quarter.
Net sales rose 4.5% to $9.4 billion; independent restaurant case volume rose 2.5%
Diluted EPS was $0.49, up 48.5%; Adjusted Diluted EPS was $0.68, up 25.9%
Board authorized a new $1 billion share repurchase program on May 7, 2025; about $52 million remained under the prior program at quarter end
Fiscal 2025 guidance reaffirmed: Net Sales growth of 4% to 6%, Adjusted EBITDA growth of 8% to 12%, Adjusted Diluted EPS growth of 17% to 23%
Warby Parker reported first-quarter 2025 net revenue of $223.8 million, up 11.9% from a year earlier, and GAAP net income of $3.5 million, its first quarter of positive net income as a public company. The company also revised its full-year 2025 guidance to net revenue of $869 million to $886 million and Adjusted EBITDA of $91 million to $97 million; the filing does not state the prior guidance figures.
Net revenue rose $23.8 million, or 11.9%, to $223.8 million; Active Customers rose 8.7% to 2.57 million.
GAAP net income was $3.5 million, compared with a net loss of $2.7 million in the first quarter of 2024.
Adjusted EBITDA rose to $29.2 million, with a margin of 13.1%, up 1.9 points.
2025 guidance: net revenue of $869 million to $886 million and Adjusted EBITDA of $91 million to $97 million, assuming the company largely mitigates tariffs at current rates.
Tapestry reported third-quarter fiscal 2025 results for the period ended March 29, 2025, with net sales of $1.58 billion, up 7% from a year earlier, and non-GAAP diluted EPS of $1.03, up 27%. The company raised its fiscal 2025 outlook, now expecting EPS in the area of $5.00 versus prior guidance of $4.85 to $4.90, and revenue of about $6.95 billion. The raised outlook and the reaffirmed plan to return over $2 billion to shareholders in fiscal 2025 are the main points for shareholders.
Q3 net sales of $1.58 billion, up 7% (8% constant currency); Coach revenue rose 13%
Q3 GAAP diluted EPS was $0.95, up from $0.60; non-GAAP diluted EPS was $1.03, up from $0.81
Fiscal 2025 EPS outlook raised to about $5.00 from $4.85 to $4.90; revenue outlook about $6.95 billion
Pending sale of Stuart Weitzman expected to close in summer 2025; quarterly dividend of $0.35 per share payable June 23, 2025
Privia Health reported first-quarter 2025 revenue of $480.1 million, up 15.6% from a year earlier, and net income attributable to the company of $4.2 million, up from $3.0 million. The company raised its full-year 2025 outlook to the mid-to-high end of most guidance ranges, with attributed lives unchanged, and said it entered Arizona through a $95 million cash acquisition of Integrated Medical Services.
Q1 2025 total revenue was $480.1 million, up from $415.2 million; operating income was $5.2 million, compared with $0.8 million
Net income per share was $0.03, compared with $0.02 in Q1 2024; non-GAAP adjusted net income per share was $0.22, compared with $0.18
Full-year 2025 GAAP revenue guidance is $1.8 billion to $1.9 billion, with most metrics raised to the mid-to-high end of ranges; attributed lives guidance is unchanged
On April 9, 2025, the company entered Arizona with the $95 million cash acquisition of Integrated Medical Services, which is expected to be profitable starting in Q4 2025
Kodiak Gas Services reported first-quarter 2025 revenue of $329.6 million and net income attributable to common shareholders of $30.4 million, both up from the fourth quarter of 2024. The company raised its full-year 2025 adjusted EBITDA guidance and increased its quarterly dividend by 10%, which benefits shareholders through higher expected cash generation and capital returns. Diluted EPS of $0.33 was below the $0.39 reported a year earlier.
Total revenues were $329.6 million, up from $309.5 million in the fourth quarter of 2024 and $215.5 million in the first quarter of 2024.
Net income attributable to common shareholders was $30.4 million; diluted EPS was $0.33, versus $0.21 in the prior quarter and $0.39 a year earlier.
Full-year 2025 adjusted EBITDA guidance was raised to $695 million to $725 million, a $10 million increase to the low end of the range.
The quarterly dividend was raised 10% to $0.45 per share, and about $10 million of common stock was repurchased at an average price of $36.87.
Atmos Energy reported results for its fiscal 2025 second quarter, which ended March 31, 2025, and raised its fiscal 2025 earnings per diluted share guidance to $7.20-$7.30 from $7.05-$7.25. The board also declared a quarterly dividend of $0.87 per share, with an indicated fiscal 2025 annual dividend of $3.48, an 8.1% increase over fiscal 2024.
Fiscal year-to-date diluted EPS of $5.26 on net income of $837.4 million
Fiscal 2025 EPS guidance raised to $7.20-$7.30 from $7.05-$7.25 per diluted share
Quarterly dividend of $0.87 per share; indicated fiscal 2025 annual dividend of $3.48, up 8.1%
Fiscal 2025 capital expenditure guidance of approximately $3.7 billion; conference call May 8, 2025 at 10:00 a.m. Eastern
Dutch Bros reported first quarter 2025 total revenues of $355.2 million, up 29.1% from $275.1 million a year earlier, and net income of $22.5 million versus $16.2 million. The company said 2025 total revenues, system same shop sales growth and adjusted EBITDA are trending toward the top half of the ranges it gave last quarter, which points to stronger expected results for shareholders.
Q1 2025 total revenues rose 29.1% to $355.2 million from $275.1 million
Diluted net income per share was $0.13 versus $0.08; adjusted EBITDA grew 19.7% to $62.9 million
Company-operated shops contribution margin was 29.4%, down 40 bps year over year
2025 guidance: total revenues $1.555 billion to $1.575 billion; adjusted EBITDA $265 million to $275 million, now trending toward the top half
Permian Resources reported first-quarter 2025 results showing higher oil and gas sales and net income attributable to Class A shares than a year earlier, and lowered the midpoint of its 2025 capital budget by $50 million. The company also agreed to buy APA Corporation's Northern Delaware Basin assets for $608 million, which is not included in its revised standalone guidance.
Oil and gas sales were $1.38 billion for Q1 2025, up from $1.24 billion a year earlier; net income attributable to Class A Common Stock was $329 million, up from $147 million, and diluted EPS was $0.44 versus $0.25.
Cash capital expenditure guidance was narrowed to $1.9 billion to $2.0 billion from $1.9 billion to $2.1 billion, while oil and total production guidance ranges were maintained.
The APA acquisition covers about 13,320 net acres and is expected to add about 12,000 Boe/d in the second half of 2025; it is expected to close by the end of the second quarter of 2025.
The board declared a $0.15 per share second quarter base dividend, and the company repurchased 4.1 million shares for $43 million in April at a weighted average price of $10.52.
Tutor Perini reported first-quarter 2025 revenue of $1.25 billion, up 19% from a year earlier, and diluted EPS of $0.53, up from $0.30. The company raised its 2025 EPS guidance to $1.60 to $1.95 from $1.50 to $1.90, and said it expects 2026 and 2027 EPS to be more than double its 2025 guidance. Operating cash flow fell to $22.9 million from $98.3 million a year earlier, which the company attributed to prior-year dispute collections.
Revenue $1.25 billion, up 19% from $1.05 billion; income from construction operations $65.3 million, up 34%
Diluted EPS $0.53 versus $0.30 a year earlier; net income attributable to the company $28.0 million
2025 EPS guidance raised to $1.60 to $1.95 from $1.50 to $1.90
Backlog record $19.4 billion at March 31, 2025, up 94%; operating cash flow $22.9 million versus $98.3 million
ESCO Technologies reported fiscal second-quarter 2025 results for the quarter ended March 31, 2025, with sales up 7% to $265.5 million and adjusted EPS up 24% to $1.35. The company raised its FY 2025 adjusted EPS guidance by $0.10 to $5.65-$5.85 excluding Maritime, and it closed the SM&P acquisition, now ESCO Maritime Solutions, on April 25.
Q2 sales were $265.5 million, up from $249.1 million; entered orders were $290.8 million, a book-to-bill of 1.10x
GAAP EPS was $1.20 versus $0.90 a year earlier; adjusted EPS was $1.35 versus $1.09
FY 2025 adjusted EPS guidance was raised to $5.65-$5.85 excluding Maritime, or $5.85-$6.15 including Maritime, from $5.55-$5.75
Q3 2025 adjusted EPS guidance excluding Maritime is $1.50-$1.60; the $0.08 quarterly dividend is payable July 17, 2025
OPENLANE reported first-quarter 2025 results, with revenue up 7% to $460.1 million and income from continuing operations of $36.9 million, up 99% from $18.5 million a year earlier. The company maintained its 2025 guidance and board approved a new share repurchase authorization of up to $250 million through December 31, 2026. For shareholders, profit growth and a larger buyback authorization stand out, though management said tariffs remain an open question for the industry.
Total operating revenues were $460.1 million, up from $429.9 million, an increase of 7%.
Income from continuing operations was $36.9 million, compared with $18.5 million; diluted EPS was $0.18, compared with $0.05.
Adjusted EBITDA was $82.8 million, up from $74.8 million a year earlier.
2025 guidance was maintained, with income from continuing operations of $100 million to $114 million and diluted EPS of $0.38 to $0.48; a new $250 million buyback runs through December 31, 2026.
EPR Properties reported first-quarter 2025 total revenue of $175.0 million, up 4.7% from a year earlier, and diluted earnings per share of $0.78 versus $0.75. The company raised its 2025 FFOAA per diluted share guidance to $5.00 to $5.16 from $4.94 to $5.14, and raised its disposition proceeds guidance to $80.0 million to $120.0 million, which matters to shareholders because it points to higher expected earnings for the full year.
Total revenue was $175.0 million, up 4.7% from $167.2 million; net income available to common shareholders was $59.8 million.
Diluted EPS was $0.78 versus $0.75; FFOAA per diluted share was $1.19 versus $1.13, up 5.3%.
2025 FFOAA per diluted share guidance rose to $5.00 to $5.16 from $4.94 to $5.14; investment spending guidance was kept at $200.0 million to $300.0 million.
The monthly dividend was raised 3.5% to $0.295 per share, payable April 15, 2025; after quarter-end the company repaid $300.0 million of notes due April 1, 2025 using its credit facility.
ADMA Biologics reported first-quarter 2025 revenue of $114.8 million, up 40% from a year earlier, and GAAP net income of $26.9 million, up 51%. The company raised its 2025 total revenue guidance to more than $500 million and its 2026 guidance to $625 million or more, and its board authorized a share repurchase program of up to $500 million with no expiration date.
Q1 2025 revenue was $114.8 million versus $81.9 million in Q1 2024; GAAP net income was $26.9 million versus $17.8 million.
FY 2025 total revenue guidance was raised to more than $500 million; FY 2026 total revenue guidance was raised to $625 million or more.
The board authorized a share repurchase program of up to $500 million, which the filing says has no expiration date.
On May 5, 2025 the company borrowed $30.0 million under its Ares revolving credit facility and used it to repay $30.0 million of its term loan; $2.5 million of the term loan remains outstanding.
Remitly reported first quarter 2025 revenue of $361.6 million, up 34% from a year earlier, and net income of $11.4 million, compared with a net loss of $21.1 million in the first quarter of 2024. The company raised its full-year 2025 revenue outlook to $1.574 billion to $1.587 billion and its Adjusted EBITDA outlook to $195 million to $210 million, and it guided to a GAAP net loss for the second quarter.
Q1 2025 revenue was $361.6 million, up 34%; send volume rose 41% to $16.2 billion.
Q1 2025 net income was $11.4 million, versus a net loss of $21.1 million a year earlier; Adjusted EBITDA was $58.4 million, up 157%.
Full-year 2025 revenue outlook raised to $1.574 billion to $1.587 billion, from $1.565 billion to $1.580 billion.
Second-quarter 2025 guidance calls for revenue of $383 million to $385 million and a GAAP net loss.
EVERTEC reported first-quarter 2025 revenue of $228.8 million, up 11% from $205.3 million a year earlier, and GAAP net income attributable to common shareholders of $32.7 million, or $0.50 per diluted share, compared with $0.24 a year earlier. The company raised its constant currency revenue and constant currency adjusted earnings per share outlook for 2025, which matters to shareholders because it signals higher expected results for the full year.
Revenue rose 11% to $228.8 million; constant currency revenue was $235.5 million, up 15%
GAAP net income attributable to common shareholders was $32.7 million, or $0.50 per diluted share, versus $16.0 million, or $0.24, a year earlier
Adjusted earnings per common share was $0.87, up 21% from $0.72
2025 constant currency revenue outlook is $903 million to $911 million; constant currency adjusted EPS outlook is $3.44 to $3.53
Veracyte reported first-quarter 2025 total revenue of $114.5 million, up 18% from a year earlier, and net income of $7.0 million, compared with a net loss of $1.9 million in the same quarter of 2024. The company reiterated its 2025 testing revenue guidance of $470 million to $480 million and raised its adjusted EBITDA margin outlook to 22.5% from 21.6%, but it also said its French subsidiary Veracyte SAS has entered collective proceedings in a Marseille commercial court and that the parent will no longer fund that entity.
Total revenue $114.5 million, up 18%; testing revenue $107.3 million, up 19%
Net income $7.0 million, or $0.09 diluted per share, versus a net loss of $1.9 million a year earlier
2025 adjusted EBITDA margin guidance raised to 22.5% from 21.6%; testing revenue guidance reiterated at $470 million to $480 million
Veracyte SAS court process expected to finish by end of 2025; the company recorded $3.8 million of related expense in the quarter
Universal Technical Institute reported fiscal second-quarter 2025 revenue of $207.4 million, up 12.6%, and net income of $11.4 million, up 47.0%, with diluted EPS of $0.21 versus $0.14. The company raised its full-year fiscal 2025 guidance across its key metrics, including revenue of $825 million to $835 million, which points to stronger expected results for shareholders.
Q2 revenue of $207.4 million, up from $184.2 million; net income of $11.4 million, up from $7.8 million
Diluted EPS of $0.21 for the quarter ended March 31, 2025, compared with $0.14 a year earlier
FY2025 revenue guidance raised to $825 million-$835 million from $810 million-$820 million; diluted EPS guidance raised to $1.00-$1.08 from $0.96-$1.04
FY2025 adjusted EBITDA guidance raised to $124 million-$128 million from $122 million-$126 million
LegalZoom reported first-quarter 2025 revenue of $183.1 million, up 5% year-over-year, and net income of $5.1 million, up 8%. The company reiterated its full-year 2025 outlook of about 5% revenue growth and Adjusted EBITDA of about $165 million, and its board raised the stock repurchase authorization by $100.0 million to $315.0 million in total.
Revenue of $183.1 million, up 5%; subscription revenue of $116.3 million, up 8%
Net income of $5.1 million, up 8% from $4.7 million; Adjusted EBITDA of $37.0 million, up 33%
Board approved a $100.0 million buyback increase; about $150.0 million remained available as of May 7, 2025
Q2 2025 revenue outlook of $181 million to $185 million; full-year guidance reiterated, not changed
BGC Group reported first-quarter 2025 results with record revenues of $664.2 million, up 14.8% from a year earlier, and GAAP fully diluted EPS of $0.11 versus $0.10. Adjusted EBITDA fell 4.1% to $199.8 million because the prior-year period included a $36.6 million mark-to-market gain, and the company said it completed its OTC Global Holdings acquisition on April 1, 2025.
Q1 2025 revenues $664.2 million vs. $578.6 million in Q1 2024; GAAP net income for fully diluted shares $52.8 million vs. $46.4 million
Post-tax Adjusted Earnings per share $0.29 vs. $0.25, up 16.0%
Q2 2025 guidance: revenues $715 million to $765 million; pre-tax Adjusted Earnings $156 million to $171 million
Quarterly dividend of $0.02 per share declared May 6, 2025, payable June 10, 2025 to holders of record May 27, 2025
Johnson Controls reported fiscal second-quarter 2025 results for the three months ended March 31, 2025. Sales rose 1% to $5.7 billion (7% organically), and GAAP EPS was $0.71 versus a loss of $0.41 a year earlier, while the company raised its full-year fiscal 2025 adjusted EPS guidance to about $3.60.
Q2 sales of $5.7 billion rose 1% as reported and 7% organically; GAAP EPS was $0.71 and adjusted EPS was $0.82
Full-year fiscal 2025 adjusted EPS guidance raised to about $3.60, from about $3.50 to $3.60 previously
Fiscal Q3 guidance includes adjusted EPS of about $0.97 to $1.00 and adjusted segment EBITA margin of about 17.5%
National Vision reported first quarter 2025 results for the quarter ended March 29, 2025, with net revenue up 5.7% to $510.3 million and diluted EPS from continuing operations of $0.18, compared with $0.15 a year earlier. The company also raised certain elements of its fiscal 2025 outlook, including adjusted diluted EPS guidance of $0.59 to $0.67, up from $0.52 to $0.64.
Net revenue rose 5.7% to $510.3 million; comparable store sales grew 4.1% and adjusted comparable store sales grew 5.5%
Diluted EPS from continuing operations was $0.18 versus $0.15; adjusted diluted EPS was $0.34 versus $0.29
Fiscal 2025 adjusted operating income outlook raised to $81 million to $92 million from $73 million to $88 million
Cash balance was $80.0 million as of March 29, 2025, with total debt of $346.1 million
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.